Application of ACOSOG Z0011 criteria reduces perioperative costs

Annals of Surgical Oncology

Volumn 20, Issue 3, 2013, Pages 836-841

  Camp, Melissa S ^a   Greenup, Rachel A ^a   Taghian, Alphonse ^a   Coopey, Suzanne B ^a   Specht, Michelle ^a   Gadd, Michele ^a   Hughes, Kevin ^a   Smith, Barbara L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; COST CONTROL; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICARE; OPERATION DURATION; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; Z0011 GUIDELINE;

AXILLA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 84875215986     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2664-0     Document Type: Article

References (16)

1. AE Giuliano L McCall P Beitsch PW Whitworth P Blumencranz AM Leitch, et al. 2010 Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American college of surgeons oncology group z0011 randomized trial Ann Surg. 252 426 433 20739842
2. AE Giuliano KK Hunt KV Ballman PD Beitsch PW Whitworth PW Blumencranz, et al. 2011 Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial J Am Med Assoc. 305 569 575 10.1001/jama.2011.90 1:CAS:528:DC%2BC3MXhvVymtrg%3D
3. AS Caudle KK Hunt HM Kuerer F Meric-Bernstam A Lucci I Bedrosian, et al. 2011 Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: A practice-changing trial Ann Surg Oncol. 18 2407 2412 21327455 10.1245/s10434-011-1593-7
4. AMA (2012) CPT codes for operative procedures and pathology interpretation. https://ocm.ama-assn.org/OCM/CPTRelativeValueSearch. Accessed 9 Sep 2011.
5. Centers for Medicare and Medicaid Services (2011) Medicare reimbursement rates. http://www.cms.gov/apps/physician-fee-schedule/search/search-criteria. aspx. Accessed 16 Sep 2011.
6. JE Stahl WS Sandberg B Daily R Wiklund MT Egan JM Goldman, et al. 2006 Reorganizing patient care and workflow in the operating room: a cost-effectiveness study Surgery. 139 717 728 16782425 10.1016/j.surg.2005.12. 006
7. M Yi SH Giordano F Meric-Bernstam EA Mittendorf HM Kuerer RF Hwang, et al. 2010 Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database Ann Surg Oncol. 17 S343 S351 10.1245/s10434-010-1253-3
8. WP Weber M Barry MM Stempel MJ Junqueira AA Eaton SM Patil, et al. 2012 A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete? Ann Surg Oncol. 19 225 232 21647763 10.1245/s10434-011-1823-z
9. H Verry SJ Lord A Martin G Gill CK Lee K Howard, et al. 2012 Effectiveness and cost-effectiveness of sentinel node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis Br J Cancer. 106 1045 1052 22415293 10.1038/bjc.2012.62 1:STN:280:DC%2BC38zhtVGmtA%3D%3D
10. D Black M Specht JM Lee F Dominguez M Gadd K Hughes, et al. 2007 Detecting occult malignancy in prophylactic mastectomy preoperative MRI versus sentinel lymph node biopsy Ann Surg Oncol. 14 2477 2484 17587091 10.1245/s10434-007-9356-1
11. A Lucci LM McCall PD Beitsch PW Whitworth DS Reintgen PW Blumencranz, et al. 2007 Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011 J Clin Oncol. 25 3657 3663 17485711 10.1200/JCO.2006.07.4062
12. YCT Shih Y Xu JN Cormier S Giordano SH Ridner TA Buchholz, et al. 2009 Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2 year follow-up study J Clin Oncol. 27 2007 2014 19289624 10.1200/JCO.2008.18.3517
13. NL Stout LA Pfalzer B Springer E Levy CL McGarvey JV Danoff, et al. 2012 Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care Phys Ther. 92 152 163 21921254 10.2522/ptj.20100167
14. KK Hunt M Yi EA Mittendorf C Guerrero GV Babiera I Bedrosian, et al. 2009 Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients Ann Surg. 250 558 566 19730235
15. JM Classe V Bordes L Campion H Mignotte F Dravet J Leveque, et al. 2009 Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study J Clin Oncol. 27 726 732 19114697 10.1200/JCO.2008.18.3228
16. EP Mamounas A Brown S Anderson R Smith T Julian B Miller, et al. 2005 Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27 J Clin Oncol. 23 2694 2702 15837984 10.1200/JCO.2005.05.188